Molecular and Pharmacological Characterisation of Pathways Which Determine the Sensitivity of Cells to Anti-Cancer Drugs and Chemopreventive Agents

StatusFinished
Effective start/end date1/07/141/05/16

Funding

  • Cancer Research UK (C4639/A10822): £643,447.00
  • Cancer Research UK (A10822): £133,109.00
  • Cancer Research UK (C4639/A22357): £54,144.37
  • Cancer Research UK (C4639/A15709): £58,051.00